How to Cope with Allergies & Asthma in 2017

In 2017, Live Science is bringing our readers a monthly series on personal health goals, with tips and tricks we’ve gathered from the many health experts we’ve interviewed. Each month, we’ll focus on a different goal, and the goal for March is exercise.

Why asthmatics are less able to fight off flu

London, March 10 – People with asthma are likely to have worse symptoms when they get the flu and are more likely to end up in hospitals because of immune system differences, researchers said. The study showed that when exposed to the flu virus, people with asthma have weaker immune systems, whereas healthy people show a strong immune system-triggering reaction.

Richard L. Wang Named Chief Executive Officer of Fosun Kite…

Richard L. Wang Named Chief Executive Officer of Fosun Kite Biotechnology Co., Ltd., a Joint Venture to Lead Development of Axicabtagene Ciloleucel and Other Engineered T-Cell Therapies for Treatment of Cancers in China Kite Pharma, Inc., today announced that Richard L. Wang, Ph.D. will be appointed Chief Executive Officer of Fosun Kite Biotechnology Co., Ltd, the company’s 50/50 owned joint venture in China with Shanghai Fosun Pharmaceutical Co., Ltd. .The companies announced the formation of the joint venture in early 2017 to develop, manufacture and commercialize autologous T-cell therapies to treat cancer in China, including Kite’s lead cell therapy product candidate, axicabtagene ciloleucel.

Novan Announces Presentation of Anti-Viral Data at International Papillomavirus Conference

Novan, Inc. today announced that preclinical data demonstrating the anti-viral effects of the Company’s nitric oxide-releasing drug candidates will be presented at the 31st International Papillomavirus Conference in Cape Town, South Africa. Thomas Broker, Ph.D., and Louise Chow, Ph.D., both of the University of Alabama at Birmingham, or UAB, are scheduled to present “Antiviral Efficacy of Nitric Oxide-Releasing Drug Candidates in Suppressing Productive Infection by HPV-18 in the Organotypic Epithelial Raft Culture Model System” on Thursday, Mar. 2. Drs.

SBP researchers identify new regulator of innate immune response to foreign invaders

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a new regulator of the innate immune response – the immediate, natural immune response to foreign invaders. The study, published recently in Nature Microbiology , suggests that therapeutics that modulate the regulator – an immune checkpoint – may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments for autoimmune disease.

Why Men Are Much Worse At Being Sick Than Women

… Sabra Klein, associate professor of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health. “It isn’t always the presence of the microbe or the presence of the virus that makes us sick,” says Klein. “It’s our immune …

Could there FINALLY be a cure for the common cold?

Experts say they have discovered the hidden code for the cold which could pave the way for a treatment being available. However it could still be some time off yet, scientists working on the pioneering study estimated a cure for the virus could hit shops in ten years’ time.

Hamburg chiropractor to celebrate 30

… his 30th anniversary, Dr. Karas has no plans for retirement or even semi-retirement. According to him, “health is wealth” and he looks forward to the future and expanding the practice to include an associate, an individual massage area …

Research may show new ways to repress inflammation at outset

Researchers at the University of Tubingen, working with colleagues in other parts of Germany and in the United States, have identified an enzyme as a kind of biological gauge regulating inflammation in the human body. Professor Alexander Weber of the Interfaculty Institute of Cell Biology says the enzyme – Bruton’s tyrosine kinase or BTK – is switched on when an inflammation occurs in the body, playing a key role in the inflammation’s subsequent development.

Antiviral Therapeutics Technologies, Markets and Companies Report…

Dublin, Feb. 21, 2017 — Research and Markets has announced the addition of Jain PharmaBiotech’s new report “Antiviral Therapeutics – Technologies, Markets and Companies” to their offering. This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics.

Myriad’s Prolaris Test Significantly Improves the Risk…

Myriad Genetics, Inc. , a global leader in personalized medicine, today announced new data demonstrating the utility of the ProlarisA test to more accurately classify mortality risk and guide the management of newly diagnosed men with prostate cancer. The data are being presented at the 2017 Genitourinary Cancers Symposium meeting in Orlando, Fla.

Studies reveal link between rotator cuff disease and genetics

A new study presented this week at the Association of Academic Physiatrists Annual Meeting in Las Vegas shows rotator cuff disease might be a heritable trait. Rotator cuff disease is a common disorder that affects 30 to 50 percent of people over the age of 50. The disease often leads to shoulder pain and loss of function.

Genes point to who develops lung disease, study finds

Scientists unveiled a trove of newly-discovered gene variants on Monday to help predict who will most likely develop a killer lung disease, both among smokers and non-smokers. The world’s biggest probe of the genetics of lung health yielded 43 new gene variants linked to chronic obstructive pulmonary disease , a major cause of death.

Virginia Tech researchers receive NIH grant to improve malaria drug

As long as parasites continue to mount resistance to malaria drugs, scientists will be faced with the task of developing new, improved pharmaceuticals. A research team from the Virginia Tech Center for Drug Discovery has received a $431,126 two-year grant from the National Institutes of Health to make improved versions of a promising compound called MMV008138, or 8138 for short.

Jefferson researchers reveal new insight into two states of viral protein

To generate swarms of new viral particles, a virus hijacks a cell into producing masses of self-assembling cages that are then loaded with the genetic blueprint for the next infection. But the picture of how that DNA is loaded into those viral cages, or capsids, was blurry, especially for two of the most common types of DNA virus on earth, bacterial viruses and human herpesvirus.

Research findings could lead to effective repair therapies for peripheral nerve damage

Research published today, 30th January 2017 online in the Journal of Cell Biology , has for the first time identified how a bodily protein allows nerves of the peripheral nervous system to repair following injury. The findings, discovered by research neuroscientists at Plymouth University Peninsula Schools of Medicine and Dentistry and funded by the Medical Research Council, could lead to effective repair therapies for those who have suffered peripheral nerve damage in trauma cases or perhaps via battlefield injuries.

Murine Study Finds Potential Boost for Ovarian Cancer Drug Olaparib

Researchers from the Chinese Academy of Sciences have discovered that the metabolic enzyme phosphoglycerate mutase 1 helps cancer cells repair their DNA and found that inhibiting PGAM1 sensitizes tumors to the cancer drug Olaparib . Their findings in the study ” Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells ,” which has been published in The Journal of Cell Biology , suggest that this FDA-approved ovarian cancer medicine has the potential to treat a wider range of cancer types than currently indicated.